Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?

被引:45
|
作者
Jones, Tiffanie [1 ]
Neboori, Hanmanth [2 ]
Wu, H. [2 ]
Yang, Qifeng [3 ]
Haffty, Bruce G. [2 ]
Evans, Susan [1 ]
Higgins, Susan [1 ]
Moran, Meena S. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] UMDNJ Robert Wood Johnson Sch Med, New Brunswick, NJ USA
[3] Shangdong Univ, Jinan, Peoples R China
关键词
TRIPLE-NEGATIVE PHENOTYPE; BASAL-LIKE SUBTYPE; MOLECULAR SUBTYPE; CONSERVATION THERAPY; AXILLARY DISSECTION; HORMONE-RECEPTOR; SURVIVAL; OUTCOMES; BIOPSY; WOMEN;
D O I
10.1245/s10434-013-2994-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer subtypes (BCS) determined from immunohistochemical staining have been correlated with molecular subtypes and associated with prognosis and outcomes, but there are limited data correlating these BCS and axillary node involvement. This study was conducted to assess whether BCS predicted for nodal metastasis or was associated with other clinicopathologic features at presentation. Patients with stage I/II disease who underwent breast-conserving surgery and axillary surgical assessment with available tissue blocks underwent a institutional pathological review and construction of a tissue microarray. The slides were stained for estrogen receptor, progesterone receptor, and HER-2/neu (HER-2) for classification into BCS. Nodal involvement and other clinicopathologic features were analyzed to assess associations between BCS and patient and tumor characteristics. Outcomes were calculated a function of BCS. The study cohort consisted of 453 patients (luminal A 48.6 %, luminal B 16.1 %, HER-2 11.0 %, triple negative 24.2 %), of which 22 % (n = 113) were node positive. There were no significant associations with BCS and pN stage, node positivity, or absolute number of nodes involved (p > 0.05 for all). However, there were significant associations with subtype and age at presentation (p < 0.001), method of detection (p = 0.049), tumor histology (p < 0.001), race (p = 0.041), and tumor size (pT stage, p < 0.001) by univariate and multivariate analysis. As expected, 10-year outcomes differed by BCS, with triple negative and HER-2 subtypes having the worse overall (p = 0.03), disease-free (p = 0.03), and distant metastasis-free survival (p < 0.01). There is a significant association between BCS and age, T stage, histology, method of detection, and race, but no associations to predict nodal involvement. If additionally validated, these findings suggest that BCS may not be a useful prognostic variable for influencing regional management considerations.
引用
收藏
页码:2866 / 2872
页数:7
相关论文
共 50 条
  • [31] Nodal Radiation in Early-Stage Breast Cancer: Who Is Most Likely to Benefit?
    Bellon, Jennifer R.
    Harris, Jay R.
    BREAST DISEASES, 2016, 27 (01): : 19 - 20
  • [32] The impact of nodal micrometastasis on mortality among women with early-stage breast cancer
    Javaid Iqbal
    Ophira Ginsburg
    Vasily Giannakeas
    Paula A. Rochon
    John L. Semple
    Steven A. Narod
    Breast Cancer Research and Treatment, 2017, 161 : 103 - 115
  • [33] Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016?
    Dess R.T.
    Speers C.W.
    Pierce L.J.
    Current Breast Cancer Reports, 2016, 8 (2) : 95 - 104
  • [34] Clinicopathologic Features and Survival of Breast Cancer Subtypes in Northeast Iran
    Shahidsales, Soodabeh
    Joudi, Mona
    Mirsadraee, Marjaneh
    Avan, Amir
    Simab, Saeideh Ahmadi
    Ghavamnasiri, Mohammad-Reza
    MIDDLE EAST JOURNAL OF CANCER, 2018, 9 (01) : 27 - 33
  • [35] REVIEW OF TRADITIONAL PROGNOSTIC AND PREDICTIVE MARKERS IN EARLY-STAGE BREAST CANCER
    Plun-Favreau, J.
    Luthman, S.
    Svedman, C.
    Mesterton, J.
    BREAST, 2013, 22 : S58 - S58
  • [36] RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients
    Giorello, Maria Belen
    Borzone, Francisco Raul
    Mora, Maria Florencia
    Padin, Maria del Rosario
    Wernicke, Alejandra
    Labovsky, Vivian
    Chasseing, Norma Alejandra
    CANCER BIOMARKERS, 2024, 41 (02) : 115 - 132
  • [37] DIETARY EXPOSURES AND OTHER FACTORS OF POSSIBLE PROGNOSTIC-SIGNIFICANCE IN RELATION TO TUMOR SIZE AND NODAL INVOLVEMENT IN EARLY-STAGE BREAST-CANCER
    HEBERT, JR
    TOPOROFF, E
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (03) : 518 - 526
  • [38] FACTORS PREDICTING THE NODAL INVOLVEMENT IN EARLY BREAST CANCER
    Elmadahm, A.
    Gill, P.
    Farshid, G.
    Gebski, V.
    Bilous, M.
    Lord, S.
    Chee, L.
    Wetzig, N.
    BREAST, 2014, 23 (04): : S5 - S5
  • [39] Sarcoidosis mimicking metastatic breast cancer in a patient with early-stage breast cancer
    Altinkaya, Metin
    Altinkaya, Naime
    Hazar, Burhan
    TURKISH JOURNAL OF SURGERY, 2016, 32 (01) : 71 - 74
  • [40] Accelerated partial breast irradiation in early-stage breast cancer
    Sanders, Mary Ella
    Scroggins, Troy
    Ampil, Federico L.
    Li, Benjamin D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (08) : 996 - 1002